De Rosa G - Search Results

1

Deletions of 17p are associated with transition from early to advanced colorectal cancer.

Risio M, Casorzo L, Chiecchio L, De Rosa G, Rossini FP. Risio M, et al. Among authors: de rosa g. Cancer Genet Cytogenet. 2003 Nov;147(1):44-9. doi: 10.1016/s0165-4608(03)00188-2. Cancer Genet Cytogenet. 2003. PMID: 14580770

2

Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy.

Martincich L, Montemurro F, Cirillo S, Marra V, De Rosa G, Ponzone R, Aglietta M, Regge D. Martincich L, et al. Among authors: de rosa g. Radiol Med. 2003 Jul-Aug;106(1-2):51-8. Radiol Med. 2003. PMID: 12951551 English, Italian.

3

HER2 testing in gastric cancer: molecular morphology and storage time-related changes in archival samples.

Risio M, De Rosa G, Sarotto I, Casorzo L, Capussotti L, Torchio B, Aglietta M, Chiecchio L. Risio M, et al. Among authors: de rosa g. Int J Oncol. 2003 Nov;23(5):1381-7. Int J Oncol. 2003. PMID: 14532980

4

Survivin expression in oral squamous cell carcinoma.

Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggiò MA, Procaccini M, Ferrari F, De Rosa G, Altieri DC. Lo Muzio L, et al. Among authors: de rosa g. Br J Cancer. 2003 Dec 15;89(12):2244-8. doi: 10.1038/sj.bjc.6601402. Br J Cancer. 2003. PMID: 14676801 Free PMC article.

5

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.

Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M, Biglia N, Sarotto I, Sismondi P, Regge D, Aglietta M. Martincich L, et al. Among authors: de rosa g. Breast Cancer Res Treat. 2004 Jan;83(1):67-76. doi: 10.1023/B:BREA.0000010700.11092.f4. Breast Cancer Res Treat. 2004. PMID: 14997056

6

HER2 and central nervous system metastasis in patients with breast cancer.

Montemurro F, Sarotto I, Casorzo L, Pisacane A, Aglietta M, De Rosa G. Montemurro F, et al. Among authors: de rosa g. Clin Breast Cancer. 2004 Aug;5(3):232-4. doi: 10.3816/cbc.2004.n.027. Clin Breast Cancer. 2004. PMID: 15335457

7

Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer.

Montemurro F, Martincich L, De Rosa G, Cirillo S, Marra V, Biglia N, Gatti M, Sismondi P, Aglietta M, Regge D. Montemurro F, et al. Among authors: de rosa g. Eur Radiol. 2005 Jun;15(6):1224-33. doi: 10.1007/s00330-005-2656-6. Epub 2005 Jan 27. Eur Radiol. 2005. PMID: 15906034

8

The influence of hormone replacement therapy on the pathology of breast cancer.

Biglia N, Sgro L, Defabiani E, De Rosa G, Ponzone R, Marenco D, Sismondi P. Biglia N, et al. Among authors: de rosa g. Eur J Surg Oncol. 2005 Jun;31(5):467-72. doi: 10.1016/j.ejso.2005.02.005. Eur J Surg Oncol. 2005. PMID: 15922881

9

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.

Carnevale-Schianca F, Cignetti A, Capaldi A, Vitaggio K, Vallario A, Ricchiardi A, Sperti E, Ferraris R, Gatti M, Grignani G, Rota-Scalabrini D, Geuna M, Fizzotti M, Sangiolo D, Sottile A, De Rosa G, Bucci AR, Lambertenghi-Deliliers G, Benedetti E, Nash R, Aglietta M. Carnevale-Schianca F, et al. Among authors: de rosa g. Blood. 2006 May 1;107(9):3795-803. doi: 10.1182/blood-2005-10-3945. Epub 2006 Jan 10. Blood. 2006. PMID: 16403911

10

Silencing the MET oncogene leads to regression of experimental tumors and metastases.

Corso S, Migliore C, Ghiso E, De Rosa G, Comoglio PM, Giordano S. Corso S, et al. Among authors: de rosa g. Oncogene. 2008 Jan 24;27(5):684-93. doi: 10.1038/sj.onc.1210697. Epub 2007 Aug 6. Oncogene. 2008. PMID: 17684486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results